holding, under different statute, that parent company may be liable when it operates a facility, as evidenced by parent’s participation in the activities of the facility
How later courts described this case
- holding, under different statute, that parent company may be liable when it operates a facility, as evidenced by parent’s participation in the activities of the facility
- “Proof of damage to the government is not required.”
- pointing out the “frequency and level of detail” of communication between subsidiary and corporate officials as well as the parent’s involvement in fraudulent activity
Written by the judges who cited it.
The opinion
UNITED STATES DISTRICT COURT
DISTRICT OF MASSACHUSETTS
___________________________________
)
UNITED STATES OF AMERICA ex rel. )
CHRISTINE MARTINO-FLEMING, Relator )
) Civil Action
Plaintiffs, ) No. 15-13065-PBS
)
v. )
)
SOUTH BAY MENTAL HEALTH CENTER, )
INC.; COMMUNITY INTERVENTION )
SERVICES, INC.; H.I.G. GROWTH )
PARTNERS, LLC; H.I.G. CAPITAL, )
LLC; PETER J. SCANLON; AND )
KEVIN P. SHEEHAN )
)
Defendants. )
_________________________________ )
MEMORANDUM AND ORDER
September 21, 2018
Saris, C.J.
INTRODUCTION
Relator Christine Martino-Fleming brings this action under
the federal False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq.,
against South Bay Mental Health Center, Inc. (“South Bay”), and
its owners and operators. She alleges that South Bay routinely
submitted bills for the mental-health services of unlicensed,
unqualified, and unsupervised employees to MassHealth, the
Massachusetts Medicaid program, and its contractors. The
Defendants are South Bay; H.I.G. Growth Partners, LLC (“H.I.G.
Growth”), and H.I.G. Capital, LLC (“H.I.G. Capital”)
(collectively, “H.I.G. Defendants”); Community Intervention
Services, Inc. (“C.I.S.”); Peter J. Scanlon; and Kevin P.
Sheehan.
Relator’s Complaint asserts counts under both the FCA and
its Massachusetts counterpart. The Commonwealth subsequently
intervened and filed a 27-count Complaint-in-Intervention. The
United States elected not to intervene. Defendants have filed
motions to dismiss both complaints under Rule 12(b)(6) and Rule
9(b) of the Federal Rules of Civil Procedure.
Because the Commonwealth has intervened, its Complaint-in-
Intervention supersedes the Relator’s Complaint with respect to
the state-law claims. The motions to dismiss regarding those
claims are discussed in a separate opinion, with which the Court
assumes familiarity. This memorandum addresses the Relator’s
three federal-law counts that remain at issue: False Claims, 31
U.S.C. § 3729(a)(1)(A) (Count 1); False Statements Material to
False Claims, 31 U.S.C. § 3729(a)(1)(B) (Count 2); and Reverse
False Claims, 31 U.S.C. § 3729(a)(1)(G) (Count 3).
For the reasons stated below, the Court DENIES the motions
to dismiss Counts 1 and 2, and ALLOWS the motions to dismiss
Count 3.
FACTUAL BACKGROUND
The facts below are taken from the Relator’s 250-paragraph
Second Amended Complaint (“SAC”). Many are disputed.
I. MassHealth
The Massachusetts Medicaid program, known as MassHealth,
covers mental-health services. It is jointly financed by the
federal and state governments. The state has promulgated
regulations governing mental-health services provided by the
MassHealth program. See generally 130 Mass. Code Regs.
§§ 401.401-650.035. Among other things, MassHealth regulations
provide that unlicensed counselors must be under the “direct and
continuous supervision” of a licensed psychiatrist,
psychologist, independent clinical social worker, or psychiatric
nurse to provide mental health services. Id. § 429.424.
Most MassHealth beneficiaries enroll in managed care plans
such as a Managed Care Organization (“MCO”) plan or a Primary
Care Clinician (“PCC”) plan. People not enrolled in these plans
receive mental-health services on a fee-for-service basis. The
MCOs contract with MassHealth, and MassHealth pays for the
services. The MCOs manage the healthcare services and have their
own authorization requirements. Id. § 508.004(B)(3). The
Massachusetts Behavioral Health Program (“MBHP”) administers and
pays for mental-health services provided to MassHealth members
enrolled in a PCC plan and has its own terms as well. See id.
§ 450.124(A). MassHealth pays MBHP and the MCOs a fixed monthly
fee for each MassHealth member.
II. South Bay
South Bay is a mental-health center that offers services to
patients throughout the Commonwealth in its 17 satellite
clinics. It is a for-profit corporation established under the
laws of Massachusetts. It was founded in 1986 by Defendant Dr.
Peter Scanlon, who was its sole officer and director, and owned
all outstanding capital stock until April 2012.
South Bay employs therapists and other professionals who do
not meet the MassHealth licensing requirements or the
requirements of its contractors. Moreover, a vast majority of
unlicensed staff therapists at South Bay clinics had no
qualified supervisor, and many South Bay clinics did not have
qualified clinic directors. Despite these alleged violations of
state law and contractual requirements, South Bay was reimbursed
for services provided by unlicensed and improperly supervised
professionals. Claim submissions by these unlicensed and
improperly supervised professionals were false and fraudulent,
Relator alleges.
III. South Bay’s Acquisition by Private Equity Investors
In April 2012, after conducting due diligence, H.I.G.
Capital and H.I.G. Growth purchased South Bay through C.I.S.
H.I.G. Capital is a Delaware limited liability company described
as a “leading global private equity investment firm with $21
billion of equity capital under management.” H.I.G. Growth, also
a Delaware limited liability company, is a capital-investment
affiliate of H.I.G. Capital and is also a multi-billion dollar
private equity company. Sheehan, the Chief Executive Officer
(“CEO”) of C.I.S., had over 30 years of behavioral health
experience.
After the acquisition, the officers and members of the
Boards of Directors of South Bay and C.I.S. overlapped:
Name South Bay C.I.S. Other
Position(s) Position(s) Position(s)
Sheehan President, CEO, Director
Director
Scanlon Treasurer, Chief Clinical
Director Officer,
Director (until
2012)
Steven Loose Director Director Managing
Director of
H.I.G.
Growth;
Senior
Member of
H.I.G.
Capital
Nicolas Scola Director Clerk, Director Principal of
H.I.G.
Growth and
H.I.G.
Capital
Eric Tencer Director Director Principal of
H.I.G.
Growth and
H.I.G.
Capital
From April 2012 on, the Board members of C.I.S. were
“heavily involved in the operational decisions of South Bay,
including approving contracts, strategic planning, budgeting,
and earnings issues.”
IV. The Whistleblower
Relator Christine Martino-Fleming is a licensed mental-
health counselor. She was employed by South Bay from June 2008
until September 2013. Thereafter, she worked for C.I.S. from
September 2013 to September 2014. Initially a Job Coach at South
Bay, she became the Coordinator of Staff Development and
Training, and was responsible for keeping track of employee
turnover. In this role, Martino-Fleming learned that all South
Bay clinics were not compliant with the Massachusetts
regulations for mental-health centers because they had staff
therapists who were unqualified, unlicensed, and unsupervised.
Between 2009 and 2015, over 60 percent of regional directors,
over 80 percent of clinical directors, and over 75 percent of
supervisors across all South Bay facilities were not properly
licensed according to MassHealth regulations, and there was a
“systemic failure to hire qualified individuals.”
Beginning in 2012, Martino-Fleming informed Scanlon and
Sheehan, as well as other C.I.S. officers, that a significant
percentage of employees at South Bay “lacked the requisite
qualifications to see, diagnose or treat patients on their own,”
and that supervisors were also unqualified in violation of
MassHealth regulations and MBHP/MCO requirements. She brought
these issues to the Boards of C.I.S. and South Bay.
V. Tiger Teams
In 2013, Scola (a principal of the H.I.G. Defendants and
senior member of H.I.G. Capital) began to examine the employee
retention issue at South Bay.1 Relator told him that South Bay’s
clinicians lacked the licensure and educational background
required by MassHealth regulations, and that they were not being
appropriately supervised. Accordingly, Scola was told none of
the billing for their services was appropriate.
As a result of these concerns, “Tiger Teams” were tasked
with investigating the cause of employee turnover and
deficiencies in the supervision of licensed clinicians at South
Bay. According to Relator, a Tiger Team was a “team of
specialists in a particular field brought together to work on
specific tasks.” These teams discovered that employees with only
associate’s degrees were diagnosing and treating patients
without supervision. They also found that clinicians sent their
notes to other sites to be signed by licensed supervisors, but
did not receive the direct and continuous supervision as
necessary. The investigation concluded that the “lack of
1 The employee retention issue is described in more detail in the
Court’s memorandum on the Commonwealth’s Complaint.
appropriate qualifications and independent licensure of
Supervisors, a lack of supervision of staff therapists, and a
lack of properly credentialed clinicians” were all leading to
high employee turnover.
The Tiger Teams recommended to the C.I.S. Board that South
Bay hire a “substantial” number of qualified supervisors “in
accordance with the legal requirements of MassHealth and its
administrative companies” to oversee the clinicians. The C.I.S.
Board rejected the recommendation of the Tiger Teams. Sheehan
and the C.I.S. Board thought the Tiger Teams were an “enormous
waste of time.”
LEGAL FRAMEWORK
“In alleging fraud or mistake, a party must state with
particularity the circumstances constituting fraud or mistake.”
Fed. R. Civ. P. 9(b). Allegations that a defendant violated the
federal False Claims Act (“FCA”) must meet this “particularity”
requirement. See D'Agostino v. ev3, Inc., 845 F.3d 1, 10 (1st
Cir. 2016).
“Rule 9(b) requires a relator to allege with particularity
the who, what, when, where, and how of the fraud.” D’Agostino,
845 F.3d at 10 (citing United States ex rel. Ge v. Takeda Pharm.
Co., 737 F.3d 116, 123 (1st Cir. 2013)). There is no “‘checklist
of mandatory requirements’ that each allegation in a complaint
must meet to satisfy Rule 9(b),” but
details concerning the dates of the claims, the
content of the forms or bills submitted, their
identification numbers, the amount of money charged to
the government, the particular goods or services for
which the government was billed, the individuals
involved in the billing, and the length of time
between the alleged fraudulent practices and the
submission of claims based on those practices are the
types of information that may help a relator to state
his or her claims with particularity.
Lawton ex rel. United States v. Takeda Pharm. Co., 842 F.3d 125,
131 (1st Cir. 2016) (quoting United States ex rel. Karvelas v.
Melrose-Wakefield Hosp., 360 F.3d 220, 233 (1st Cir. 2004)).
“[A]llegations limited to describing the defendant’s scheme and
intent are insufficient.” D’Agostino, 845 F.3d at 10. “Although
some questions [may] remain unanswered, the complaint as a whole
[must be] sufficiently particular to pass muster under the FCA.”
United States ex rel. Gagne v. City of Worcester, 565 F.3d 40,
45 (1st Cir. 2009) (quoting United States ex rel. Rost v.
Pfizer, Inc., 507 F.3d 720, 732 (1st Cir. 2007)).
The First Circuit has applied a “more flexible” Rule 9(b)
standard in certain cases where a defendant is alleged to have
induced third parties to file false claims. See United States ex
rel. Allen v. Alere Home Monitoring, Inc., Civ. No. 16-11372-
PBS, 2018 WL 4119667, at *6 (D. Mass. Aug. 29, 2018) (and cases
cited). This line of cases holds that Rule 9(b) may be satisfied
where reliable indicia, such as factual or statistical evidence,
“strengthen the inference of fraud beyond possibility” even
without details as to each false claim. Id.
In any event, “[b]ecause FCA liability attaches only to
false claims merely alleging facts related to a defendant’s
alleged misconduct is not enough.” Takeda Pharm. Co., 737 F.3d
at 124 (emphasis in original) (internal citation omitted).
“Thus, the allegations must also establish that the fraudulent
conduct actually caused the submission of false claims to the
government for payment.” D’Agostino, 845 F.3d at 10 (citing
Takeda Pharm. Co., 737 F.3d at 124).
DISCUSSION
I. False Claims and False Statements (Counts 1 and 2)
In Count 1, Relator alleges that all Defendants knowingly,
or in deliberate ignorance or reckless disregard for the truth,
caused false claims to be presented to the United States for
payment from MassHealth, MBHP, and MCOs in violation of 31
U.S.C. § 3729(a)(1)(A). The claims were allegedly false in
material ways because Defendants misrepresented compliance with
the MassHealth regulations concerning the supervision and
qualifications of clinicians. In Count 2, Relator alleges that
Defendants knowingly made false statements about the
qualifications of individual practitioners in violation of 31
U.S.C. § 3729(a)(1)(B). The Relator does not assert an alter ego
or veil piercing theory; rather, her argument hinges on direct
liability.
A. Causation
Defendants argue that Relator does not articulate how any
of them directly caused South Bay to submit false claims. Their
primary argument is that the alleged failure to stop South Bay’s
policy and practice of submitting false claims for services by
unqualified and unsupervised clinicians is insufficient to
impose FCA liability on H.I.G. and C.I.S. They argue that the
FCA requires “affirmative” steps to “cause” the submission of
claims in order to impose liability.
The FCA, in relevant part, creates liability for
anyone who
(A) knowingly presents, or causes to be presented, a
false or fraudulent claim for payment or
approval; [or who]
(B) knowingly makes, uses, or causes to be made or
used, a false record or statement material to a
false or fraudulent claim.
31 U.S.C. § 3729(a)(1). No intent to defraud is required by the
statute. Id. § 3729(b)(1) (“[T]he terms ‘knowing’ and
‘knowingly’ . . . require no proof of specific intent to
defraud.”); Universal Health Servs., Inc. v. United States ex
rel. Escobar, 136 S. Ct. 1989, 1999 n.2 (2016).
The purpose of the FCA is “to reach any person who
knowingly assisted in causing the government to pay claims which
were grounded in fraud, without regard to whether that person
had direct contractual relations with the government.” United
States ex rel. Marcus v. Hess, 317 U.S. 537, 544-45 (1943),
superseded by statute on other grounds as recognized in
Schindler Elevator Corp. v. United States ex rel. Kirk, 563 U.S.
401, 412 (2011).
“Generally, mere knowledge of the submission of claims and
knowledge of the falsity of those claims is insufficient to
establish ‘causation’ under the FCA.” United States v. President
and Fellows of Harvard Coll., 323 F. Supp. 2d 151, 186 (D. Mass.
2004). “To ‘cause’ the presentation of false claims under the
FCA, some degree of participation in the claims process is
required.” Id. at 186-87. However, the FCA does not always
require an “affirmative act” to impose liability. For example,
“a defendant may be liable if it operates under a policy that
causes others to present false claims.” Id. at 187. Moreover,
[w]here the defendant has an ongoing business
relationship with a repeated false claimant, and the
defendant knows of the false claims, yet does not cease
doing business with the claimant or disclose the false
claims to the United States, the defendant’s ostrich-
like behavior itself becomes “a course of conduct that
allowed fraudulent claims to be presented to the federal
government.”
Id. (quoting United States ex rel. Long v. SCS Bus. & Tech.
Inst., 999 F.Supp. 78, 91 (D.D.C. 1998)). A defendant may be
liable where the submission of false claims by another entity
was the foreseeable result of a business practice. See, e.g.,
United States ex rel. Franklin v. Parke-Davis, 147 F. Supp. 2d
39, 52 (D. Mass. 2001).
Here, the Relator alleges that she and the Tiger Teams
expressly informed the CEO and Boards of C.I.S. and South Bay
that the supervision of clinical workers violated state
regulations and recommended that a substantial number of
licensed supervisors be hired to fix the problem, and that the
recommendation was rejected. The allegation that C.I.S. and
Sheehan, the CEO, knowingly ratified the prior policy of
submitting false claims by rejecting recommendations to bring
South Bay into regulatory compliance constitutes sufficient
participation in the claims process to trigger FCA liability.
Because it is alleged that H.I.G. members and principals
formed a majority of the C.I.S. and South Bay Boards, and were
directly involved in the operations of South Bay, the motion to
dismiss the H.I.G. entities is also denied. A parent may be
liable for the submission of false claims by a subsidiary where
the parent had direct involvement in the claims process. See,
e.g., United States ex rel. Hockett v. Columbia/HCA Healthcare
Corp., 498 F. Supp. 2d 25, 62-63 (D.D.C. 2007) (pointing out the
“frequency and level of detail” of communication between
subsidiary and corporate officials as well as the parent’s
involvement in fraudulent activity); cf. United States v.
Bestfoods, 524 U.S. 51, 68 (1998) (holding, under different
statute, that parent company may be liable when it operates a
facility, as evidenced by parent’s participation in the
activities of the facility).
Finally, because of Scanlon’s role at South Bay as the sole
owner and person primarily responsible for ensuring compliance
with MassHealth regulations, Relator plausibly alleges Scanlon
had sufficient participation in submission of the false claims
to be liable under the FCA.
B. Materiality
Next, Defendants argue that the Complaint fails to allege
that the violations of the state regulations were material or
that they knew about the materiality. This argument is
unpersuasive. For the reasons stated in the Court’s memorandum
regarding the Commonwealth’s Complaint-in-Intervention, the
Court concludes that the Relator adequately alleges that the
violations of the MassHealth regulations are indeed material,
and that each defendant knew about, or was deliberately ignorant
of, those violations.
The Court addresses separately the claims submitted to the
MCOs and MBHP. Defendants argue that Relator has not
sufficiently pleaded that violations of the MassHealth
regulations were material to payment decisions made by the MCOs
and MBHP, which have their own supervision and credentialing
criteria. This argument is without merit because Plaintiffs have
alleged that MBHP and the MCOs would deny payment had they known
of South Bay’s failure to comply with MassHealth regulations.
However, Defendants also argue that Relator fails to allege
with particularity which requirements South Bay failed to meet
under the different contracts of each MCO and MBHP. The Court
agrees. Although these contractual criteria are mentioned in
multiple places throughout the SAC, Relator does not appear to
base Counts 1 or 2 on breaches of these separate requirements,
nor does she allege that the violations of these contractual
provisions are material to the extent they are different from
the state regulations. Thus, the motion to dismiss is allowed
insofar as it is based on the MCO or MBHP criteria.
II. Reverse False Claims (Count 3)
Relator alleges that Defendants knowingly concealed,
avoided, or decreased an obligation to pay money to the United
States. The theory is that South Bay’s failure to return the
overpayments once it was aware of the regulatory violations
constitutes a reverse false claim, and that Scanlon, Sheehan,
C.I.S., and H.I.G. are liable under the reverse false claims
provision because they were “aware of the overpayments and
responsible to report them, but failed to do so.” Relator states
that this is only an alternative theory of liability. Perhaps
for this reason, it is a poorly briefed and underdeveloped
claim.
The reverse false claims provision of the FCA imposes
liability in two scenarios. First, it applies when a person
“knowingly makes, uses, or causes to be made or used, a false
record or statement material to an obligation to pay or transmit
money or property to the Government.” 31 U.S.C. § 3729(a)(1)(G).
Second, it applies when a person “knowingly conceals or
knowingly and improperly avoids or decreases an obligation to
pay or transmit money or property to the Government.” Id.
Although the Complaint uses language from both scenarios, only
the second is meaningfully advanced.
By statute, an “obligation” is “an established duty,
whether fixed or not, arising from . . . the retention of any
overpayment.” 31 U.S.C. § 3729(b)(3). As relevant to this case,
the term “overpayment” means “any funds that a person receives
or retains under [Medicare or Medicaid] to which the person,
after applicable reconciliation, is not entitled.” 42 U.S.C.
§ 1320a-7k(d)(4)(B). Moreover, if a person –- which includes a
“provider of services, supplier, [or] medicaid managed care
organization” -- has received an overpayment, the person must
“report and return the overpayment” to the government. 42 U.S.C.
§ 1320a-7k(d)(1)(A), (d)(4)(C)(i).
Relator’s Complaint fails to adequately allege that any of
the Defendants incurred an “obligation” within this statutory
framework. As a general matter, “to retain -- to not return --
an overpayment constitutes a violation of the FCA.” Kane ex rel.
United States v. Healthfirst, Inc., 120 F. Supp. 3d 370, 394
(S.D.N.Y. 2015). But “there is no liability for obligations to
pay that are merely potential or contingent.” United States ex
rel. Barrick v. Parker-Migliorini Int’l, LLC, 878 F.3d 1224,
1231 (10th Cir. 2017), petition for cert. filed, No. 17-1509
(U.S. May 7, 2018). Indeed, the Senate specifically struck
“contingent” duties from the proposed statutory language. 1 John
T. Boese, Civil False Claims and Qui Tam Actions § 2.01[L], at
2-84 (4th ed. Supp. 2018). Nor can reverse-FCA liability be
premised solely on the same conduct that gives rise to
traditional presentment or false-statement claims. See Pencheng
Si v. Laogai Research Found., 71 F. Supp. 3d 73, 97 (D.D.C.
2014); accord Boese, Civil False Claims and Qui Tam Actions §
2.01[L] at 2-83 (“[R]everse false claim liability cannot be
premised solely on the conduct that creates the obligation.”).
Under these principles, South Bay cannot be liable for a
reverse false claim because Relator does not adequately allege
that South Bay took any action independent of the main FCA
theories already discussed. Because South Bay’s conduct forms
the foundation for the reverse-FCA theory against the other
Defendants, Relator’s reverse-FCA claims against them fail as
well. That is, Relator has not adequately explained how any of
the other Defendants had an “established” -- as opposed to a
potential or contingent – “obligation” to repay funds to the
government. In this case, an “overpayment” only exists where the
recipient, “after applicable reconciliation, is not entitled” to
the disputed funds. 42 U.S.C. § 1320a-7k(d)(4)(B). Here, there
is no allegation that any such “reconciliation” occurred, nor is
it clear what that would look like given that the parties’
entitlement vel non to Medicaid reimbursements is the subject of
this very litigation.
With respect to Scanlon and Sheehan, Relator also has not
plausibly alleged that they “knowingly” or “improperly”
concealed or avoided any overpayments. See Boese, Civil False
Claims and Qui Tam Actions § 2.01[L] at 2-83 (noting that
“improperly” denotes “either improper motive or inherently
improper means”).31 U.S.C. § 3729(a)(1)(G). Finally, with
respect to C.I.S. and the H.I.G. Defendants, it is not alleged
that these Defendants are “persons” as defined by statute
because they are not a “provider of services, supplier, or
managed care organization.” Accordingly, the reverse-FCA count
is dismissed as to all Defendants.
III. Remaining Arguments (All Counts)
A. Particularity Under Rule 9(b)
Defendants also argue that the SAC is not pleaded with
sufficient particularity as required by Fed. R. Civ. P. 9(b).
This argument is rejected for the same reasons stated in the
memorandum addressing the Commonwealth’s Complaint-in-
Intervention.
B Supervision of Clinicians
Defendants argue the claims alleged are not false as a
matter of law because “an unlicensed clinician need not receive
clinical supervision from his or her administrative supervisor.”
Distinguishing between “administration supervision” and
“licensure supervision,” they contend that South Bay’s
unlicensed clinicians received adequate licensure supervision
(as opposed to administrative supervision), which in their view,
is sufficient under the regulations.
Relator cites two MassHealth regulations applicable to
supervision. First, all staff members must receive supervision
appropriate to the person’s skills and level of professional
development. See 130 Mass. Code Regs. § 429.438(E)(1)
(“Frequency and extent of supervision must conform to the
licensing standards of each discipline’s Board of
Registration.”). Second, 130 Mass. Code Regs. § 429.424 sets
forth the “Qualifications of Professional Staff Members
Authorized to Render Billable Mental Health Center Services by
Core Discipline.” It provides that “[a]ll unlicensed counselors
. . . must be under the direct and continuous supervision of a
fully qualified professional staff member trained in one of the
core disciplines” of psychiatry, social work, psychology, and
psychiatric nursing. Id. §§ 429.424(A)-(D), (F)(1).
Relator alleges that South Bay failed to provide both types
of supervision. She further alleges that files were effectively
rubber-stamped by so-called “licensed signatories,” who would
sign off on documents without meeting patients or counselors.
Moreover, she alleges that unlicensed, unqualified clinicians
did not receive any supervision whatsoever for the first 90
days. These allegations are sufficient to state a claim.
Defendants also argue that the SAC must be dismissed
because the regulations allow clinic directors to be “licensed,
certified, or registered to practice in one of the core
disciplines listed,” 130 Mass. Code Regs. § 429.423, and
although Relator alleges that they were unlicensed, she did not
specify whether they were also unregistered or uncertified. It
is true that the focus of Relator’s SAC is that the treating
professionals are unlicensed. However, she also alleges that
therapists “lacked the correct type of license, registration or
certification in one of the core disciplines” as required by the
regulations. Therefore, this argument is without merit.
C. Capitated Payments
Finally, Defendants argue that the claims involving MCOs
and MBHP fail because these government contractors are paid on a
capitated basis at a fixed rate per patient regardless of the
service offered. A “claim” is defined by statute to include
claims of payment of government funds made to government
contractors. See 31 U.S.C. § 3729(b)(2). Here, Relator alleges
that South Bay submitted false claims and made false statements
to Medicaid contractors who paid the bills with Medicaid funds
as a result. The fact that Medicaid did not suffer damages
because it paid a capitated rate does not negate liability
because liability attaches to the “claim for payment.” United
States v. United Healthcare Ins. Co., 848 F.3d 1161, 1173 (9th
Cir. 2016) (“Proof of damage to the government is not
required.”).
ORDER
The Court dismisses Count 3 (reverse false claims) as to
all Defendants. Counts 1 and 2 remain viable. Accordingly, the
motions to dismiss by South Bay (Dkt. No. 101), the H.I.G. and
C.I.S. Defendants (Dkt. No. 103), Sheehan (Dkt. No. 106), and
Scanlon (Dkt. No. 109) are ALLOWED IN PART and DENIED IN PART.
/s/ PATTI B. SARIS____________
Honorable Patti B. Saris
Chief U.S. District Judge